Draft dQM CMS Content Implementation Guide
2025.1.0 - CI Build

Draft dQM CMS Content Implementation Guide, published by cqframework. This guide is not an authorized publication; it is the continuous build for version 2025.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cqframework/dqm-content-cms-2025/ and changes regularly. See the Directory of published versions

Measure: Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer PatientsFHIR

Official URL: https://madie.cms.gov/Measure/CMS129FHIRProstCaBoneScanUse Version: 1.0.000
Active as of 2026-01-16 Responsible: Centers for Medicare & Medicaid Services (CMS) Computable Name: CMS129FHIRProstCaBoneScanUse
Other Identifiers: Short Name: CMS129FHIR (use: usual, ), UUID:a9fa2b95-f5f7-4ff4-931c-b47df9d6371f (use: official, ), UUID:2bdfa3ee-eaa5-42ae-8483-a71dc6d3521f (use: official, ), Publisher: 129FHIR (use: official, )

Copyright/Legal: This electronic clinical quality measure (Measure) and related data specifications are owned and stewarded by the Centers for Medicare \& Medicaid Services (CMS). CMS contracted (Contract # 75FCMC18D0027/ Task Order #: 75FCMC24F0144) with the American Institutes for Research (AIR) to develop this electronic measure. AIR is not responsible for any use of the Measure. AIR makes no representations, warranties, or endorsement about the quality of any organization or physician that uses or reports performance measures and AIR has no liability to anyone who relies on such measures or specifications.

Limited proprietary coding is contained in the Measure specifications for user convenience. Users of proprietary code sets should obtain all necessary licenses from the owners of the code sets.

AIR disclaims all liability for use or accuracy of any third-party codes contained in the specifications.

CPT(R) contained in the Measure specifications is copyright 2004-2023 American Medical Association. LOINC(R) is copyright 2004-2023 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2023 International Health Terminology Standards Development Organisation. ICD-10 is copyright 2023 World Health Organization. All Rights Reserved.

Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy who did not have a bone scan performed at any time since diagnosis of prostate cancer

Exception generating Narrative: Unable to Parse HTML - node 'td' has unexpected content ' ' (last text = 'Risk Strata: Very Low/Low Risk: PSA \' at line 479 column 69